Skip to content

Pirtobrutinib significantly improves PFS in patients with treatment-naïve CLL/SLL
“Promising” early-phase results seen with KLN-1010, an off-the-shelf in vivo CAR-T for myeloma
Teclistamab plus daratumumab improves survival compared with SOC triplet therapy in relapsed/refractory MM
Phase 3 study finds fixed-duration treatment non-inferior to continuous treatment in CLL
Extended MorningSun study results show ‘promising’ survival with subcutaneous mosunetuzumab

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Pathways & Perspectives with Valeria Santini, MD

Cellular Therapy

Pathways & Perspectives with Valeria Santini, MD

Leukemia

Pathways & Perspectives with Valeria Santini, MD

Lymphoma

Pathways & Perspectives with Valeria Santini, MD

Multiple Myeloma

Pathways & Perspectives with Valeria Santini, MD

Myelodysplastic Syndromes

Pathways & Perspectives with Valeria Santini, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

December 9, 2025

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Myelodysplastic Syndromes

MDS News

Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndromes News

Pathways & Perspectives with Valeria Santini, MD

by Leah Sherwood
November 25, 2025
0 Comments

FDA editorial

Myelodysplastic Syndromes News

FDA grants orphan drug designation to MDS investigational therapy ofirnoflast

by SOHO Insider Editors
October 23, 2025
0 Comments

Digital tools

ESMO 2025 Acute Lymphoblastic Leukemia Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes

Despite digital advances, cancer research remains costly, burdensome

by Leah Sherwood
October 22, 2025
0 Comments

Update

ESMO 2025 Myelodysplastic Syndromes News

Bexmarilimab continues to show strong efficacy in phase 1/2 trial update

by Leah Sherwood
October 21, 2025
0 Comments

Presenter speaking

Ambassador Program Myelodysplastic Syndromes Society Updates

SOHO MENA returns to in-person meeting for region’s 3rd meeting

by SOHO Insider Editors
October 20, 2025
0 Comments

Uma Borate presentation

SOHO 2025 Educational Resources Leukemia Meetings / Conferences Myelodysplastic Syndromes News

Improving Outcomes in CHIP/CCUS with Dr. Borate

by SOHO Insider Editors
October 20, 2025
0 Comments

FDA stamp on white paper

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA accepts BLA for Orca-T in hematological malignancies

by SOHO Insider Editors
October 15, 2025
0 Comments

Time for Phase 2. Hand holds a cube with number '2'. Word 'Phase 2'. Beautiful black background. Business concept. Copy space.

Acute Myeloid Leukemia Myelodysplastic Syndromes

Oral decitabine and cedazuridine combo shows promise as post-HSCT option

by Leah Sherwood
August 21, 2025
0 Comments

a globe

Acute Myeloid Leukemia Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

by SOHO Insider Editors
August 11, 2025
0 Comments

SOHO Insider podcast

SOHO 2025 Meeting News Myelodysplastic Syndromes News SOHO Insider Podcast

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

by Leah Sherwood
July 23, 2025
0 Comments

1
2
3

Top Categories

Cellular Therapy

13

Leukemia

71

Lymphoma

67

Multiple Myeloma

63

Myelodysplastic Syndromes

24

Myeloproliferative Neoplasms

12

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Cellular Therapy

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Leukemia

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Lymphoma

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Multiple Myeloma

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Myelodysplastic Syndromes

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Pirtobrutinib significantly improves PFS in patients with treatment-naïve CLL/SLL

“Promising” early-phase results seen with KLN-1010, an off-the-shelf in vivo CAR-T for myeloma

Time to phase 3 symbol. Concept word Phase 1 2 3 on wooden block. Businessman hand. Beautiful grey table grey background. Business planning and time to phase 3 concept. Copy space.

Teclistamab plus daratumumab improves survival compared with SOC triplet therapy in relapsed/refractory MM

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.